| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:08:04 -0700 |
| HMDB ID |
HMDB00202 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Methylmalonic acid |
| Description |
Methylmalonic acid is a malonic acid derivative which is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 1,1-Ethanedicarboxylate
- 1,1-Ethanedicarboxylic acid
- 2-Methylmalonate
- 2-Methylmalonic acid
- Isosuccinate
- Isosuccinic acid
- Methyl-Malonate
- Methyl-Malonic acid
- Methyl-Propanedioate
- Methyl-Propanedioic acid
- Methylmalonate
- Methylmalonic acid
- Methylpropanedioate
- Methylpropanedioic acid
|
| Chemical Formula |
C4H6O4 |
| Average Molecular Weight |
118.088 |
| Monoisotopic Molecular Weight |
118.02660868 |
| IUPAC Name |
2-methylpropanedioic acid |
| Traditional IUPAC Name |
methylmalonic acid |
| CAS Registry Number |
516-05-2 |
| SMILES |
CC(C(O)=O)C(O)=O |
| InChI Identifier |
InChI=1S/C4H6O4/c1-2(3(5)6)4(7)8/h2H,1H3,(H,5,6)(H,7,8) |
| InChI Key |
ZIYVHBGGAOATLY-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Organic Acids and Derivatives |
| Class |
Carboxylic Acids and Derivatives |
| Sub Class |
Dicarboxylic Acids and Derivatives |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Dicarboxylic acids(Lipidmaps)
- dicarboxylic acid(ChEBI)
|
| Substituents |
|
| Direct Parent |
Dicarboxylic Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
- Cytoplasm (predicted from logP)
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
135 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
679.0 mg/mL |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 1H NMR Spectrum |
| 13C NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 10 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 20 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 30 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 40 |
| MS/MS Spectrum LC-ESI-QQ (API3000, Applied Biosystems) 50 |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum GC-MS |
| MS/MS Spectrum GC-MS |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm (predicted from logP)
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.14 (0.04-0.26) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
0.187 +/- 0.084 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
0.17 (0.073-0.27) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
0.200 (0.00-0.400) uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.40 (0.16-0.59) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.51 +/- 0.13 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.32 +/- 0.11 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.92 +/- 1.97 umol/mmol creatinine |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal |
Urine compound detected by GC-MS
|
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.58 (0.0-3.29) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.0 +/- 0.7 umol/mmol creatinine |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
4.0 +/- 0.9 umol/mmol creatinine |
Children (1-13 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.8 (0.00-3.6) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.50 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.9 (0.7-3.5) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
0.64 +/- 0.39 umol/mmol creatinine |
Children (1-13 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.17 +/- 0.11 umol/mmol creatinine |
Adolescent (13-18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.51 +/- 1.01 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.6 (0-3.60) umol/mmol creatinine |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
9.4 (0.1-79.4) umol/mmol creatinine |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
29.9 (0.1-78.9) umol/mmol creatinine |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
8.2 (1.5-30.8) umol/mmol creatinine |
Children (1-13 year old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
3.7 (1.1-21.6) umol/mmol creatinine |
Adolescent (13-18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.3 (0.5-2.1) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
by GC-MS
|
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
11.2 uM |
Adult (>18 years old) |
Not Specified |
Heart Transplant |
Not Available |
| Blood |
Detected and Quantified |
|
22.0 (4.3-37.0) uM |
Adult (>18 years old) |
Both |
Cobalamin deficiency |
Not Available |
| Blood |
Detected and Quantified |
|
0.480 +/- 0.062 uM |
Adult (>18 years old) |
Both |
Alzheimer's disease |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.30 +/- 0.12 uM |
Elderly (>65 years old) |
Not Specified |
Alzheimer's disease |
Not Available |
| Urine |
Detected and Quantified |
|
325.00 (150.00-500.00) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Transcobalamin deficiency |
Not Available |
| Urine |
Detected and Quantified |
|
16.0 (1.5-30.8) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Cobalamin malabsorption |
Not Available |
| Urine |
Detected and Quantified |
|
275.0 (50.0-500.0) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Cobalamin malabsorption |
Not Available |
| Urine |
Detected and Quantified |
|
7825.00 (150.00-15500.00) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Malonyl CoA decarboxylase deficiency |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Alzheimer's disease |
- Serot JM, Barbe F, Arning E, Bottiglieri T, Franck P, Montagne P, Nicolas JP: Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2005 Nov;76(11):1585-7.
Pubmed: 16227558
- Kristensen MO, Gulmann NC, Christensen JE, Ostergaard K, Rasmussen K: Serum cobalamin and methylmalonic acid in Alzheimer dementia. Acta Neurol Scand. 1993 Jun;87(6):475-81.
Pubmed: 8356878
|
| Vitamin B12 deficiency |
- Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.
Pubmed: 8412012
|
| Cobalamin malabsorption |
- http://www.metagene.de/program/d.prg?mp=COBALAMIN%20MALABSORPTION
|
| Malonyl-Coa decarboxylase deficiency |
- http://www.metagene.de/program/d.prg?mp=MALONYL-COA%20DECARBOXYLASE%20DEFICIENCY
|
| Transcobalamin II deficiency |
- http://www.metagene.de/program/d.prg?mp=TRANSCOBALAMIN%20II%20DEFICIENCY
|
|
| Associated OMIM IDs |
- 104300
(Alzheimer's disease)
- 248360
(Malonyl-Coa decarboxylase deficiency)
- 275350
(Transcobalamin II deficiency)
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021905 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
473  |
| KEGG Compound ID |
C02170  |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Methylmalonic acid  |
| NuGOwiki Link |
HMDB00202  |
| Metagene Link |
HMDB00202  |
| METLIN ID |
3712  |
| PubChem Compound |
487  |
| PDB ID |
DXX  |
| ChEBI ID |
30860  |
| References |
| Synthesis Reference |
Edamura, Koji; Arai, Takeshi. Malonic and methylmalonic acids from b-hydroxypropionic acids. Jpn. Kokai Tokkyo Koho (1979), 5 pp. |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- van Asselt DZ, Karlietis MH, Poels PJ, de Jong JG, Wevers RA, Hoefnagels WH: Cerebrospinal fluid methylmalonic acid concentrations in neurological patients with low and normal serum cobalamin concentrations. Acta Neurol Scand. 1998 Jun;97(6):413-6.
Pubmed: 9669477
- Magera MJ, Helgeson JK, Matern D, Rinaldo P: Methylmalonic acid measured in plasma and urine by stable-isotope dilution and electrospray tandem mass spectrometry. Clin Chem. 2000 Nov;46(11):1804-10.
Pubmed: 11067816
- Nakamura E, Rosenberg LE, Tanaka K: Microdetermination of methylmalonic acid and other short chain dicarboxylic acids by gas chromatography: use in prenatal diagnosis of methylmalonic acidemia and in studies of isovaleric acidemia. Clin Chim Acta. 1976 Apr 15;68(2):127-40.
Pubmed: 1261058
- Jakobs C, Sweetman L, Nyhan WL: Hydroxy acid metabolites of branched-chain amino acids in amniotic fluid. Clin Chim Acta. 1984 Jul 16;140(2):157-66.
Pubmed: 6467607
- Coude MM, Charpentier C, Bonnefont JP, Cheron G, Kamoun P: Organic acids in aqueous humour and plasma: post mortem study in infants and diagnosis of enzymopathies. J Inherit Metab Dis. 1991;14(5):668-73.
Pubmed: 1779612
- Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6.
Pubmed: 8087979
- Aleszczyk J: [Connection between changing the vitamin and immune status and the character of the throat microflora in patients with chronic tonsillitis] Otolaryngol Pol. 2003;57(2):221-4.
Pubmed: 12894427
- Nagarajan S, Enns GM, Millan MT, Winter S, Sarwal MM: Management of methylmalonic acidaemia by combined liver-kidney transplantation. J Inherit Metab Dis. 2005;28(4):517-24.
Pubmed: 15902554
- Stabler SP, Marcell PD, Podell ER, Allen RH, Lindenbaum J: Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. J Clin Invest. 1986 May;77(5):1606-12.
Pubmed: 3700655
- Jellum E, Stokke O, Eldjarn L: Combined use of gas chromatography, mass spectrometry, and computer in diagnosis and studies of metabolic disorders. Clin Chem. 1972 Aug;18(8):800-9.
Pubmed: 4557757
- Leupold D: [Methylmalonic aciduria. Classification, diagnosis and therapy (author's transl)] Klin Wochenschr. 1977 Jan 15;55(2):57-63.
Pubmed: 319293
- Vrethem M, Mattsson E, Hebelka H, Leerbeck K, Osterberg A, Landtblom AM, Balla B, Nilsson H, Hultgren M, Brattstrom L, Kagedal B: Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler. 2003 Jun;9(3):239-45.
Pubmed: 12814169
- Bennett MJ, Ragni MC, Hood I, Hale DE: Comparison of post-mortem urinary and vitreous humour organic acids. Ann Clin Biochem. 1992 Sep;29 ( Pt 5):541-5.
Pubmed: 1444166
- Haurani FI, Hall CA, Rubin R: Megaloblastic anemia as a result of an abnormal transcobalamin II (Cardeza). J Clin Invest. 1979 Nov;64(5):1253-9.
Pubmed: 500809
- Frenkel EP, Kitchens RL: Applicability of an enzymatic quantitation of methylmalonic, propionic, and acetic acids in normal and megaloblastic states. Blood. 1977 Jan;49(1):125-37.
Pubmed: 830370
|